Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 22, 2022 05:00 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction

NORTH BRUNSWICK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage, private company developing therapies for inflammatory, infectious, and degenerative diseases...